Insulin Adjustment Recommendations for This Patient
Based on the blood glucose pattern showing adequate basal control (fasting 141 mg/dL at 0200) but significant postprandial excursions, this patient needs adjustment of his insulin-to-carbohydrate ratio (ICR) rather than his basal insulin dose, and his current insulin sensitivity factor (ISF) appears appropriate.
Analysis of Current Glucose Pattern
The glucose data reveals:
- Baseline BG 155 mg/dL at noon
- After 67g carbohydrate → BG 223 mg/dL (rise of 68 mg/dL)
- After 20g carbohydrate → BG 188 mg/dL
- Overnight BG 141 mg/dL at 0200 (acceptable fasting level)
The overnight glucose of 141 mg/dL indicates the basal insulin (Lantus 6 units) is working adequately. The problem is postprandial hyperglycemia, suggesting insufficient prandial insulin coverage.
Recommended Adjustments
Basal Insulin (Lantus)
Keep at 6 units daily - the overnight glucose of 141 mg/dL demonstrates adequate basal coverage. The 2025 ADA guidelines recommend targeting fasting plasma glucose goals individualized to the patient, and for a 70-year-old, this level is reasonable 1.
Insulin-to-Carbohydrate Ratio (ICR)
Change from 1:10 to 1:8 (1 unit per 8 grams of carbohydrate)
The current 1:10 ratio is insufficient. At noon, 67g carbohydrate should have received approximately 6.7 units with the current ratio, but the 68 mg/dL rise suggests inadequate coverage. Using the standard formula of 500/TDD (total daily dose), if we estimate this patient needs roughly 40-50 units total daily insulin based on his weight and current control, the ICR should be closer to 1:10 to 1:8 2.
Starting point: Use 1 unit per 8g carbohydrate, which can be empirically adjusted based on response 2.
Insulin Sensitivity Factor (ISF)
Keep at 1:50 (1 unit lowers glucose by 50 mg/dL)
Using the 1800 rule for rapid-acting insulin: 1800/TDD. If TDD is approximately 40 units, ISF = 1800/40 = 45-50 mg/dL per unit, which aligns with his current ISF of 50 2. This appears appropriate and should be maintained initially.
Important Considerations for This 70-Year-Old Patient
Age-Related Factors
For older adults (≥70 years), the 2025 ADA guidelines recommend starting with lower insulin doses (0.2-0.3 units/kg/day) to minimize hypoglycemia risk 1. This patient's current low basal dose of 6 units is appropriately conservative.
Empagliflozin (Jardiance) Interaction
The patient is on Jardiance 5 mg, which provides additional glucose lowering through renal glucose excretion. This SGLT2 inhibitor:
- Reduces insulin requirements by 6-13% 3
- Does NOT increase hypoglycemia risk when combined with basal insulin 4
- Should be continued as it provides cardiovascular and renal benefits
Critical warning: Counsel the patient about euglycemic diabetic ketoacidosis risk with SGLT2 inhibitors, especially if considering low-carbohydrate diets 5. Symptoms include nausea, vomiting, and abdominal pain even with normal glucose levels.
Hypoglycemia Prevention
Given his age, prioritize hypoglycemia avoidance:
- Set less stringent A1C goals (<8.0% is acceptable for a 70-year-old with intermediate health status) 6
- Prescribe glucagon for emergency use 7
- Educate on treating hypoglycemia with 15g fast-acting carbohydrates at glucose <70 mg/dL 7
- Review hypoglycemia symptoms and treatment at every visit
Titration Algorithm
- Implement new ICR of 1:8 for all meals
- Monitor fasting and 2-hour postprandial glucose for 3-5 days
- Adjust ICR by 1-2g increments if:
- Postprandial glucose consistently >180 mg/dL → tighten ratio (e.g., 1:7)
- Postprandial glucose <100 mg/dL → loosen ratio (e.g., 1:9)
- Reassess in 2-3 weeks and adjust based on glucose patterns 1
Common Pitfalls to Avoid
- Do not increase basal insulin when the problem is postprandial hyperglycemia - this increases hypoglycemia risk without addressing the actual issue
- Do not use sliding scale insulin alone - this reactive approach is inferior to carbohydrate counting with ICR 8
- Do not discontinue Jardiance - it provides important benefits and does not increase hypoglycemia risk with insulin 3, 4
- Avoid aggressive titration in elderly patients - make small adjustments and monitor closely 9
The patient should continue Jardiance 5 mg, maintain Lantus at 6 units daily, adopt the new ICR of 1:8, and keep ISF at 1:50, with close monitoring and adjustment based on response over the next 2-3 weeks 1, 2.